Technical Analysis for RBOT - Vicarious Surgical Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 5.40 | -8.01% | -0.47 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -8.01% | |
| Expansion Breakdown | Bearish Swing Setup | -8.01% | |
| Reversal New Lows Setup | Bearish Swing Setup | -8.01% | |
| Volume Surge | Other | -8.01% | |
| New 52 Week Low | Weakness | -8.01% | |
| Outside Day | Range Expansion | -8.01% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 9 hours ago |
| 2x Volume Pace | about 9 hours ago |
| Reversal New Lows Entry | about 9 hours ago |
| Fell Below Previous Day's Low | about 9 hours ago |
| New 52 Week Low | about 9 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 07/25/2024
Vicarious Surgical Inc. Description
Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Telemedicine Medical Technology FDA Virtual Reality Healthcare Costs Minimally Invasive Surgery Disruptive Technology Robot Assisted Surgery Computer Assisted Surgery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 62.1 |
| 52 Week Low | 5.19 |
| Average Volume | 28,829 |
| 200-Day Moving Average | 11.29 |
| 50-Day Moving Average | 8.91 |
| 20-Day Moving Average | 8.20 |
| 10-Day Moving Average | 6.74 |
| Average True Range | 1.03 |
| RSI (14) | 24.24 |
| ADX | 50.85 |
| +DI | 4.67 |
| -DI | 39.27 |
| Chandelier Exit (Long, 3 ATRs) | 7.95 |
| Chandelier Exit (Short, 3 ATRs) | 8.28 |
| Upper Bollinger Bands | 11.48 |
| Lower Bollinger Band | 4.91 |
| Percent B (%b) | 0.07 |
| BandWidth | 80.20 |
| MACD Line | -0.95 |
| MACD Signal Line | -0.69 |
| MACD Histogram | -0.2599 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.51 | ||||
| Resistance 3 (R3) | 6.56 | 6.25 | 6.33 | ||
| Resistance 2 (R2) | 6.25 | 5.96 | 6.22 | 6.26 | |
| Resistance 1 (R1) | 5.82 | 5.79 | 5.67 | 5.77 | 6.20 |
| Pivot Point | 5.51 | 5.51 | 5.43 | 5.48 | 5.51 |
| Support 1 (S1) | 5.08 | 5.22 | 4.93 | 5.03 | 4.60 |
| Support 2 (S2) | 4.77 | 5.05 | 4.74 | 4.54 | |
| Support 3 (S3) | 4.34 | 4.77 | 4.48 | ||
| Support 4 (S4) | 4.29 |
